portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


Shanghai Kehua Bio-Engineering Co.,Ltd.(002022.SZ)

Profile
Registered Capital:
492.28(RMB MLN)
Employees:
925
Email:
shkh@sh163.net

WebSite:
http://www.skhb.com/news/english/index.shtml
Tel:
021-64850088
Fax:
021-64851044
Introduction from Google Finace
Shanghai Kehua Bio-Engineering Co., Ltd. is a China-based company engaged in manufacture and sale of biological products. The Company provides clinical in-vitro diagnostic agents, including clinical in-vitro diagnostic agents of immunoassay, clinical in-vitro diagnostic chemical agents and clinical in-vitro diagnostic agents of nucleic acid, among others, as well as genetic engineering drugs and automatic detection devices. The Company distributes its products within domestic markets and to overseas markets. During the year ended December 31, 2010, the Company obtained approximately 49% and 48% from the sale of clinical in-vitro diagnostic agents and medical devices, respectively.
Revenue Breakdown (million RMB)
Industry20102010H120092009H120082007
Biological products777.74**********
Total--**********
Products20102010H120092009H120082007
In vitro diagnostic reagents************
Medical devices************
Other************
Total************
Area20102010H120092009H120082007
Domestic719.14**********
In foreign countries58.60**********
Total--**********
Introduction from Company WebSite

Shanghai Kehua Bio-Engineering Co., Ltd. is a China-based company engaged in manufacture and sale of biological products. The Company provides clinical in-vitro diagnostic agents, including clinical in-vitro diagnostic agents of immunoassay, clinical in-vitro diagnostic chemical agents and clinical in-vitro diagnostic agents of nucleic acid, among others, as well as genetic engineering drugs and automatic detection devices. The Company distributes its products within domestic markets and to overseas markets. During the year ended December 31, 2010, the Company obtained approximately 49% and 48% from the sale of clinical in-vitro diagnostic agents and medical devices, respectively.
 

2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1